Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Come On Shorties, I Dare You, this just keeps getting better
View:
Post by Dude51 on Feb 01, 2021 10:42pm

Come On Shorties, I Dare You, this just keeps getting better

https://www.ctvnews.ca/health/coronavirus/could-a-simple-gas-produced-by-our-bodies-be-used-to-treat-covid-19-canadian-trials-underway-1.4962611

https://kalyteran.co/index.php?/topic/565-sanotize-not-wasting-any-time/&tab=comments#comment-1548

It's coming, what's not to like? Sanotize is not public from any reading I did but we are....

Nice job, Robert
Comment by bud13 on Feb 02, 2021 11:28am
it all sounds great. But is our management actually doing anything during this period with progressing this product we have. Hopefully we will have a string of press releases upon retrading regarding progress made since acquiring our product. Not a bash as I still have close to 2m shares.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities